Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025)

Alphatec Holdings' (ATEC) quarterly Non-Current Deffered Revenue came in at $2.2 million in Q4 2025, down 29.68% year-on-year from $3.1 million in Q4 2024, and down 29.68% quarter-over-quarter from $3.1 million in Q4 2024.

Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends

Alphatec Holdings has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $2.2 million for Q4 2025.

  • Non-Current Deffered Revenue for Q4 2025 came in at $2.2 million, down 29.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (down 29.68% YoY), and the FY2025 annual result was $2.2 million, down 29.68% from the prior year.
  • Non-Current Deffered Revenue came in at $2.2 million for Q4 2025 at Alphatec Holdings, down from $3.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $3.1 million in Q4 2024 to a low of $2.2 million in Q4 2025.
  • The 5-year median for Non-Current Deffered Revenue is $2.8 million (2021), against an average of $2.8 million.
  • Across the five-year window, Non-Current Deffered Revenue rose 19.23% in 2024 and retreated 29.68% in 2025, its largest moves.
  • Alphatec Holdings' Non-Current Deffered Revenue stood at $2.9 million in 2021, then gained by 5.18% to $3.0 million in 2022, then declined by 14.67% to $2.6 million in 2023, then advanced by 19.23% to $3.1 million in 2024, then declined by 29.68% to $2.2 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $2.2 million (Q4 2025), $3.1 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 512.79 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Alphatec Holdings 1.34 Bn 1.20 Bn 136.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.18 Mn
Dec 31, 2024 3.10 Mn
Dec 31, 2023 2.60 Mn
Dec 31, 2022 3.05 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 2.71 Mn